Related Experiment Videos

Vascular access for haemodialysis--experience at Johannesburg Hospital

Insights

This study reviews arteriovenous fistulas for hemodialysis access, finding autogenous fistulas have better long-term patency than synthetic grafts. Needle choice impacts hemolysis during dialysis.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Dialysis Access

Background:

  • End-stage renal failure necessitates reliable hemodialysis access.
  • Arteriovenous fistulas (AVFs) and synthetic grafts are common access types.
  • Complications and patency rates vary between access modalities.

Purpose of the Study:

  • To review experience with angio-access in hemodialysis patients.
  • To compare patency rates and complications of autogenous AVFs versus synthetic grafts.
  • To evaluate the impact of dialysis needle gauge on hemolysis.

Main Methods:

  • Retrospective review of 137 autogenous AVFs (Group 1) and 33 synthetic grafts (Group 2).
  • Patency rates assessed at 2 and 4 years.
  • Complications documented, including thrombosis, aneurysm, sepsis, and operative technique.
  • Comparison of dialysis needles of different gauges, focusing on hemolysis.

Main Results:

  • Autogenous AVFs showed 2-year patency of 66% and 4-year patency of 47%.
  • Synthetic grafts had lower patency rates: 44% at 2 years and 36% at 4 years.
  • Common complications included thrombosis, aneurysm (AVFs), and sepsis (grafts).
  • No correlation found between fibrinogen levels and access failure.
  • The 16-gauge Terumo needle caused no hemolysis and was suitable for dialysis.

Conclusions:

  • Autogenous arteriovenous fistulas demonstrate superior long-term patency compared to synthetic grafts for hemodialysis access.
  • Thrombosis and technical issues are key complications for AVFs, while sepsis is a concern for grafts.
  • Appropriate dialysis needle selection, like the 16-gauge Terumo, is crucial to prevent hemolysis.

Related Concept Videos